Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Roche,Atezolizumab,Advanced NSCLC 1L combination therapy with platinum chemotherapy,Atezolizumab,,Oncology Agents and Immunosuppressants
